Brief: Evoke Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
13/03/2025 21:32
March 13 (Reuters) - Evoke Pharma Inc EVOK.O: EVOKE PHARMA Q4 OPERATING EXPENSES USD 4.5 MILLION EVOKE PHARMA INC: PROJECTS NET REVENUE IN 2025 OF APPROXIMATELY $16 MILLION Source text: ID:nGNX2ZYQv1 Further company coverage: EVOK.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary